Why Morpho's $170 million in interest seems better than Aave's $140 million in annual revenue?

Top crypto ETFs saw mixed flows as prices surged across the week.

Binance is under the spotlight again, but not for all the right reasons.

Why low inflow on debut day was not a bad sign for Morgan Stanley's MSBT?

Illicit actors jeopardizing U.S. national security are prompting leaders to come up with new rules.

The dichotomy between leaders demanding for the passage of the bill and the dropping Polymarket odds raises eyebrows.

Schiff is taking aim again at Bitcoin and Strategy. Again.

Will Sharplink's staking reward approach prove to be better than BitMine's hoarding strategy?

With Strategy's MSTR controlling 76% of Bitcoin’s institutional holdings, how will MSBT fare?

Geopolitical tensions kept crypto sentiment between “Fear” and “Extreme Fear” since 28th February.